For following the competition: what moved in each program, several studies read as one move.
- efimosfermin alfa
- ALN-CIDEB
- DR10624
- + 12 more
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Non-alcoholic Fatty Liver Disease to watchlistEvery Monday by email · turn it off any timePro · free during the beta